Influenza and Other Respiratory Viruses

Papers
(The TQCC of Influenza and Other Respiratory Viruses is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
272
83
Antigenic Characterization of H1N1 Influenza Viruses That Circulated During the 2019–2020 Season in Philadelphia, Pennsylvania81
Meeting Report: Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for Innovation68
Cost‐Effectiveness Analysis of a Maternal Vaccination Program Against Respiratory Syncytial Virus in Norway65
Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial55
Cross‐Reactive Antibody Responses to Coronaviruses Elicited by SARS‐CoV‐2 Infection or Vaccination52
Severe acute respiratory syndrome coronavirus 2 can be detected in exhaled aerosol sampled during a few minutes of breathing or coughing46
SARS‐CoV‐2 infection rate in Antananarivo frontline health care workers, Madagascar44
Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months41
Effectiveness of the XBB.1.5 COVID‐19 Vaccines Against SARS‐CoV‐2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 t36
Issue Information35
Issue Information33
Antibiotic prescription for outpatients with influenza and subsequent hospitalisation: A cohort study using insurance data33
EMARIS Conference 2023: Convergence of science, policy, and practice on acute respiratory infections in post COVID‐19 Eastern Mediterranean Region32
Comparative complete scheme and booster effectiveness of COVID‐19 vaccines in preventing SARS‐CoV‐2 infections with SARS‐CoV‐2 Omicron (BA.1) and Delta (B.1.617.2) variants: A case–case study based on30
A comparative immune response to COVID‐19 vaccination between children and adults30
A novel household‐based patient outreach pilot program to boost late‐season influenza vaccination rates during the COVID‐19 pandemic30
Avian Influenza Virus (H5N1) Was Not Detected Among Dairy Cattle and Farm Workers in Pakistan30
Effectiveness of XBB.1.5 Monovalent COVID‐19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS‐EHR Network Study29
Evaluating Bacillus Calmette–Guérin Polysaccharide Nucleic Acid as an Adjuvant for Influenza Vaccines in Mice29
Infection‐induced seroconversion and seroprevalence of SARS‐CoV‐2 among a cohort of children and youth in Montreal, Canada28
Low prevalence of seasonal influenza viruses in Hong Kong, 202228
No evidence for HPAI H5N1 2.3.4.4b incursion into Australia in 202227
Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study27
Next‐Generation Sequencing for Characterizing Respiratory Tract Virome and Improving Detection of Viral Pathogens in Children With Pneumonia24
Costs of seasonal influenza vaccination in South Africa23
An Overview of the H5N1 mRNA Vaccine Pipeline23
A Strategic Framework of SARS‐CoV‐2 Genomic Surveillance in Bangladesh23
Issue Information23
SARS‐CoV‐2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era: Input for Future Response23
Examining the Influenza A Virus Sialic Acid Binding Preference Predictions of a Sequence‐Based Convolutional Neural Network23
Risk factors for infection with influenza A(H3N2) virus on a US university campus, October–November 202123
Correction to: The Respiratory Syncytial Virus Prefusion F Protein Vaccine Attenuates the Severity of RSV‐Associated Disease in Breakthrough Infections in Adults ≥60 Years of Age22
Tracking Seasonal Influenza Trends in South Tyrol During 2022/2023 Using Genomic Surveillance Data22
Drug use and severe outcomes among adults hospitalized with influenza, 2016–201922
Coinfection of Influenza A and B and Human OC43 Coronavirus in Normal Human Bronchial Epithelial Cells21
Bidirectional Evolution of SARS‐CoV‐2 Virus in Immunocompromised Hosts21
Live‐attenuated influenza vaccine effectiveness against hospitalization in children aged 2–6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14–2015/1621
Descriptive Epidemiology of Travel and Non‐Travel Related SARS‐CoV‐2 Gamma (P.1/501Y.V3) Variant Cases in England, 202120
20
The national burden of influenza‐like illness and severe respiratory illness overall and associated with nine respiratory viruses in South Africa, 2013–201520
In‐field detection and characterization of B/Victoria lineage deletion variant viruses causing early influenza activity and an outbreak in Louisiana, 201919
Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK19
Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic19
Influenza vaccine and subsequent development of zoster19
Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain18
Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019–202018
Changing Epidemiological Pattern and Higher Disease Burden of Influenza in China, 2022 to 202518
Aetiological Fraction of Influenza, Respiratory Syncytial Virus and Other Respiratory Pathogens in Infants Aged < 1 Year Hospitalised With Respiratory and Non‐Respiratory Medical Illness in South A18
Assessment of Influenza Severity in Bhutan by Using WHO Framework Pandemic Influenza Severity Assessment (PISA): An Implementation Research Study17
A review of policies and coverage of seasonal influenza vaccination programs in the WHO Eastern Mediterranean Region17
Association between SARS‐CoV‐2 infections during pregnancy and preterm live birth17
Long‐Distance Avian Migrants Fail to Bring 2.3.4.4b HPAI H5N1 Into Australia for a Second Year in a Row17
Coronary and Cerebrovascular Events and Exacerbation of Existing Conditions After Laboratory‐Confirmed Influenza Infection Among US Veterans: A Self‐Controlled Case Series Study17
Determination of respiratory syncytial virus epidemic seasons by using 95% confidence interval of positivity rates, 2011–2021, Germany17
Factors affecting the transmission of SARS‐CoV‐2 in school settings16
Targeting Respiratory Viruses: The Efficacy of Intranasal mRNA Vaccination in Generating Protective Mucosal and Systemic Immunity Against Influenza A (H1N1)16
Issue Information16
Issue Information16
Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands16
Issue Information16
Establishing Epidemic and Intensity Thresholds After a Major Change in Respiratory Virus Surveillance in Spain in 202015
Two‐year trajectories of COVID‐19 symptoms and their association with illness perception: A prospective cohort study in Amsterdam, the Netherlands15
Community predictors of COVID‐19 cases and deaths in Massachusetts: Evaluating changes over time using geospatially refined data15
Detection of clade 2.3.4.4 highly pathogenic avian influenza H5 viruses in healthy wild birds in the Hadeji‐Nguru wetland, Nigeria 202215
Issue Information15
Prevalence of Respiratory Viruses in Children With Acute Respiratory Infections in Shanghai, China, From 2013 to 202215
Disease Burden of RSV Infections and Bronchiolitis in Young Children (< 5 Years) in Primary Care and Emergency Departments: A Systematic Literature Review15
Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom15
The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population‐based, age‐stratified sero‐epidemiological investigation15
Interactions among common non‐SARS‐CoV‐2 respiratory viruses and influence of the COVID‐19 pandemic on their circulation in New York City15
Some characteristics of clinical sequelae of COVID‐19 survivors from Wuhan, China: A multi‐center longitudinal study15
Geographic Progression of Infant Respiratory Syncytial Virus Associated Bronchiolitis Across the United States Before and Since the Onset of COVID‐19: Results From Four Health Systems, 2015–202315
Association between COVID‐19 and consistent mask wearing during contact with others outside the household—A nested case–control analysis, November 2020–October 202114
First human infection of avian influenza A(H5N6) virus reported in Lao People's Democratic Republic, February–March 202114
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network14
Acute respiratory infection emergency access in a tertiary care children hospital in Italy, prior and after the SARS‐CoV‐2 emergence14
Domination of influenza vaccine virus strains in Hong Kong, 202114
Multi‐decade national cohort identifies adverse pregnancy and birth outcomes associated with acute respiratory illness hospitalisations during the influenza season14
14
Impact of COVID‐19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children13
High‐Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults13
Relevance of comorbidities for main outcomes during different periods of the COVID‐19 pandemic13
Genomic Analysis and Tracking of SARS‐CoV‐2 Variants in Gwangju, South Korea, From 2020 to 202213
13
COVID‐19 vaccine effectiveness against hospitalization due to SARS‐CoV‐2: A test‐negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain13
BNT162b2 vaccination reduced infections and transmission in a COVID‐19 outbreak in a nursing home in Germany, 202113
Characterization of high pathogenicity avian influenza H5Nx viruses from a wild harbor seal and red foxes in Denmark, 2021 and 202213
Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 202213
Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New York City, August 2021–January 202213
Knowledge, attitudes, and practices towards seasonal influenza vaccination among pregnant women and healthcare workers: A cross‐sectional survey in Afghanistan13
Issue Information13
Applying symptom dynamics to accurately predict influenza virus infection: An international multicenter influenza‐like illness surveillance study13
Non‐invasive genomics of respiratory pathogens infecting wild great apes using hybridisation capture12
Clinical symptoms of SARS‐CoV‐2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination—A prospective multicentre cohort of health professionals 12
Epidemiologic and Virologic Characteristics of Influenza in Lao PDR, 2016–202312
Consolidating Estimates of the Incubation Period for Omicron Subvariants From the Literature and Their Comparison to the Estimate From Taiwan: A Systematic Review and Meta‐Analysis, September 202412
Issue Information12
The Detection of Influenza Virus Before and During the COVID‐19 Pandemic in Cameroon12
Bacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 202212
Coronaviruses Among Swine Workers in Northern Vietnam12
Respiratory viral detection in the plasma and cerebrospinal fluid (CSF) of young febrile infants12
Enhancing Omicron Sublineage Neutralization: Insights From Bivalent and Monovalent COVID‐19 Booster Vaccines and Recent SARS‐CoV‐2 Omicron Variant Infections12
Antiviral Effectiveness, Clinical Outcomes, and Artificial Intelligence Imaging Analysis for Hospitalized COVID‐19 Patients Receiving Antivirals11
Genetic characterization of influenza A virus subtypes H11N6, H11N7, and H11N9 isolated from free‐grazing ducks, Thailand11
Unveiling the Spectrum of Respiratory Syncytial Virus Disease in Adults: From Community to Hospital11
BNT162b2 Versus mRNA‐1273 Vaccines: Comparative Analysis of Long‐Term Protection Against SARS‐CoV‐2 Infection and Severe COVID‐19 in Qatar11
Low Levels of Neutralizing Antibodies Against SARS‐CoV‐2 KP.3.1.1 and XEC in Serum From Seniors in May 202411
Implications of the unexpected persistence of human rhinovirus/enterovirus during the COVID‐19 pandemic in Canada11
Incidence, hospitalization, and mortality in children aged 5 years and younger with respiratory syncytial virus‐related diseases: A systematic review and meta‐analysis11
Distinct influenza surveillance networks and their agreement in recording regional influenza circulation: Experience from Southeast Michigan11
Evaluating the Economic and Epidemiological Impact of RSV Hospitalizations in Southern Austria [Southern Austria Respiratory Syncytial Virus INpatient Investigation (ARNI Study)]11
Influenza surveillance systems using traditional and alternative sources of data: A scoping review11
Virological and Clinical Outcomes of Influenza Outpatients Treated With Baloxavir, Oseltamivir, or Laninamivir in the 2023–2024 Season10
Featured Cover10
COVID‐19 outbreaks in aged‐care facilities in Australia10
Issue Information10
Excess All‐Cause Mortality by Age and Gender During the COVID‐19 Pandemic in the Federation of Bosnia and Herzegovina, Bosnia and Herzegovina: 2020–202210
Inference of age‐dependent case‐fatality ratios for seasonal influenza virus subtypes A(H3N2) and A(H1N1)pdm09 and B lineages using data from the Netherlands10
Transmission of SARS‐CoV‐2 in standardised first few X cases and household transmission investigations: A systematic review and meta‐analysis10
Mortality patterns among COVID‐19 patients in two Saudi hospitals: Demographics, etiology, and treatment10
SARS‐CoV‐2 Reverse Zoonosis Among Cats in China: A One Health Investigation10
Rapid and Safe Neutralization Assay for Circulating H5N1 Influenza Virus in Dairy Cows10
Developing a sampling methodology for timely reporting of population‐based COVID‐19‐associated hospitalization surveillance in the United States, COVID‐NET 2020–202110
Inpatient burden of respiratory syncytial virus in children ≤2 years of age in Germany: A retrospective analysis of nationwide hospitalization data, 2019–202210
An Outbreak of Respiratory Viral Infections in a Professional Ice Hockey Team10
Functional decline at 1 year in hospitalized elderly pneumonia with SARS‐CoV‐2 Omicron variant: Comparison with the ancestral strain and Alpha variant9
Issue Information9
9
Clinical outcomes of COVID‐19 treated with remdesivir across the continuum of care9
Role of research Laboratories in pandemic and epidemic response in the Eastern Mediterranean Region: Experiences from COVID‐19, avian influenza, and MERS‐CoV9
Estimated mortality due to seasonal influenza in southeast of Iran, 2006/2007 to 2011/2012 influenza seasons9
Effect of planned school breaks on student absenteeism due to influenza‐like illness in school aged children—Oregon School District, Wisconsin September 2014–June 20199
9
Analysis of a city‐wide COVID‐19 prevention strategy for aged‐care facilities during third and fifth waves of COVID‐19 in Kyoto City, Kyoto, Japan9
Rapid assessment of case recruitment tools to inform integrated surveillance of influenza and other respiratory viruses in Eastern Mediterranean countries9
9
Estimated Incidence Rate of Specific Types of Cardiovascular and Respiratory Hospitalizations Attributable to Respiratory Syncytial Virus Among Adults in Germany Between 2015 and 20199
9
Hospitalisation, morbidity and outcomes associated with respiratory syncytial virus compared with influenza in adults of all ages9
Transmissibility of severe acute respiratory syndrome coronavirus 2 among household contacts of coronavirus disease 2019‐positive patients: A community‐based study in India9
Correction to ‘Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain’9
Association of Monocyte Count With Lung Function and Exercise Capacity Among Hospitalized COVID‐19 Survivors: A 2‐Year Cohort Study9
Estimating the serial intervals of SARS‐CoV‐2 Omicron BA.4, BA.5, and BA.2.12.1 variants in Hong Kong9
High Infection Risk Among Health Care Workers During the First SARS‐CoV‐2 Wave in Niamey, Niger8
Prevalence and seasonality of viral respiratory infections in a temperate climate region: A 24‐year study (1997–2020)8
Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship8
Cardiac Characteristics of Hospitalized Influenza Patients: An Interim Analysis From the FluHeart Study8
Seasonal respiratory virus circulation was diminished during the COVID‐19 pandemic8
Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient‐reported outcome system for vaccine safety remote moni8
8
Neutralizing and protective murine monoclonal antibodies to the hemagglutinin of influenza H5 clades 2.3.2.1 and 2.3.4.48
State and situation of avian influenza in the Eastern Mediterranean Region8
Trends in Hospitalisations for Vaccine Preventable Respiratory Infections Following Emergency Department Presentations in New South Wales, Australia, 2012–20228
Temporal Trends in Respiratory Infection Epidemics Among Pediatric Inpatients Throughout the Course of the COVID‐19 Pandemic From 2018 to 2023 in Fukushima Prefecture, Japan8
8
Investigating the effects of population density of residence and rural/urban classification on rate of influenza‐like illness symptoms in England and Wales8
Incidence of Hospitalization due to Influenza‐Associated Severe Acute Respiratory Infection During 2010–2019 in Bangladesh8
Sparse Evidence of Influenza C on US Dairy and Beef Cattle Farms8
The role of non‐pharmaceutical interventions on influenza circulation during the COVID‐19 pandemic in nine tropical Asian countries8
Severe acute respiratory illness surveillance for influenza in Kenya: Patient characteristics and lessons learnt8
Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults8
8
Record high parainfluenza season in children after relaxation of COVID‐19 restrictions in fall 2021—A nationwide register study in Finland8
Modifiable in‐hospital factors for 12‐month global cognition, post‐traumatic stress disorder symptoms, and depression symptoms in adults hospitalized with COVID‐198
0.14741992950439